Art

J-GLOBAL ID：201102278693711949   Reference number：11A1252546

The efficacy of extended treatment with pegylated interferon plus ribavirin in patients with HCV genotype 1 and slow virologic response in Japan

日本のHCV遺伝子型1と遅いウイルス学的応答の患者におけるペグインターフェロン+リバビリンでの延長治療の効果

Author (29)： OZE Tsugiko (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  HIRAMATSU Naoki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  YAKUSHIJIN Takayuki (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  MOCHIZUKI Kiyoshi (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  IMANAKA Kazuho (Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, JPN) ,  YAMADA Akira (Sumitomo Hospital, Osaka, JPN) ,  OSHITA Masahide (Osaka Police Hospital, Osaka, JPN) ,  KANEKO Akira (NTT West Osaka Hospital, Osaka, JPN) ,  HAGIWARA Hideki (Kansai Rousai Hospital, Amagasaki, JPN) ,  MITA Eiji (Osaka National Hospital, Osaka, JPN) ,  ITO Toshifumi (Osaka Koseinenkin Hospital, Osaka, JPN) ,  NAGASE Toshihiko (Suita Municipal Hospital, Suita, JPN) ,  INUI Yoshiaki (Hyogo Prefectural Nishinomiya Hospital, Nishinomiya, JPN) ,  HIJIOKA Taizo (Osaka Minami Medical Center, Kawachinagano, JPN) ,  TAMURA Shinji (Minoh City Hospital, Minoh, JPN) ,  YOSHIHARA Harumasa (Osaka Rousai Hospital, Sakai, JPN) ,  HAYASHI Eijiro (Kinki Central Hospital of Mutual Aid Assoc. of Public School Teachers, Itami, JPN) ,  IMAI Yasuharu (Ikeda Municipal Hospital, Ikeda, JPN) ,  KATO Michio (Minami Wakayama Medical Center, Tanabe, JPN) ,  HOSUI Atsushi (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  MIYAGI Takuya (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  YOSHIDA Yuichi (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  ISHIDA Hisashi (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  TATSUMI Tomohide (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  KISO Shinichi (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  KANTO Tatsuya (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  KASAHARA Akinori (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  TAKEHARA Tetsuo (Osaka Univ. Graduate School of Medicine, Osaka, JPN) ,  HAYASHI Norio (Kansai Rousai Hospital, Amagasaki, JPN)
Material： Journal of Gastroenterology  (J Gastroenterol)
Volume： 46  Issue： 7  Page： 944-952  Publication year： 2011 
JST Material Number： Z0748A  ISSN： 0944-1174  Document type： Article
Article type： 原著論文  Country of issue： Germany, Federal Republic of (DEU)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： hepatitis C virus 1

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1252546&from=J-GLOBAL&jstjournalNo=Z0748A") }}

JST classification (2)： Clinical application of antiviral drugs  (GW17050Z) ,  Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Substance index (1)： Ribavirin

Reference (29)：

• POYNARL, T. Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997, 349, 825-832
• KIYOSAWA, K. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma : analysis by detection of antibody to hepatitis C virus. Hepatology. 1990, 12, 671-675
• HIRAMATSU, N. Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha. J Hepatol. 1995, 22, 135-142
• KASAHARA, A. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group. Hepatology. 1998, 27, 1394-1402
• YOSHIDA, H. Interferon therapy reduces the risk for hepatocellular carcinoma : national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. Ann Intern Med. 1999, 131, 174-181

Terms in the title (7)： 日本 ,  HCV遺伝子型 ,  ウイルス学的応答 ,  患者 ,  ペグインターフェロン ,  リバビリン ,  治療